Qlife to participate in investor presentations in December 2021

Qlife will participate in two investor days in December where the company's CEO Thomas Warthoe presents the company and gives his comments on the latest report. The presentations take place digitally, in English and are followed by a question and answer session.

Wednesday, December 1 at Stora Aktiedagen in Stockholm
Time: 12.00-12.30

Thursday 2 December at Västra Hamnen in Malmö
Time: TBD

Investors, analysts and the media need to sign up for each event. The presentations will be available at each organizer.

For more information please contact:

Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34

Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).

Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.